Anpario (LON:ANP) Initiates Stock Repurchase Program

Anpario (LON:ANP) declared that its board has approved a stock buyback plan on Monday, April 27th, RTT News reports. The company plans to buyback 0 shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s management believes its stock is undervalued.

Anpario Trading Up 1.9%

LON ANP opened at GBX 494 on Tuesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.16 and a current ratio of 4.50. Anpario has a one year low of GBX 370 and a one year high of GBX 580. The company has a 50-day simple moving average of GBX 488.17 and a 200-day simple moving average of GBX 494.84. The firm has a market capitalization of £83.71 million, a PE ratio of 13.02 and a beta of 0.99.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ANP. Canaccord Genuity Group upgraded shares of Anpario to a “buy” rating and lifted their price target for the stock from GBX 457 to GBX 570 in a research note on Thursday, April 2nd. Shore Capital Group restated a “house stock” rating on shares of Anpario in a research note on Monday. One research analyst has rated the stock with a Buy rating, According to MarketBeat, Anpario currently has a consensus rating of “Buy” and an average target price of GBX 570.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.